3
-AMINO-2-QUINOXALINECARBONITRILE
743
2
3
. Monge, A.; Palop, J. A.; Urbasos, I.; Fernandez-Alvarez, E. New quinoxaline and pyri-
mido[4,5-b]quinoxaline derivatives: Potential antihypertensive and blood platlet anti-
aggregating agents. J. Heterocycl. Chem. 1989, 26, 1623–1626.
. Urquiola, C.; Vieites, M.; Aguirre, G., Marın, A.; Solano, B.; Arrambide, G.; Noblia, P.;
Lavaggi, M. L.; Torre, M. H.; Gonzalez, M.; Monge, A.; Gambino, D.; Cerecetto, H.
1
4
Improving anti-trypanosomal activity of 3-aminoquinoxaline-2-carbonitrile N ,N -
dioxide derivatives by complexation with vanadium. Bioorg. Med. Chem. 2006, 14,
5503–5509.
4
5
. Torre, M. H.; Gambino, D.; Araujo, J.; Cerecetto, H.; Gonz a´ lez, M.; Lavaggi, M. L.;
Azqueta, A.; L o´ pez de Cerain, A.; Monge Vega, A.; Abram, U.; Costa-Filho, A. J. Novel
Cu(II) quinoxaline N ,N -dioxide complexes as selective hypoxic cytotoxins. Eur. J. Med.
Chem. 2005, 40, 473–480.
1
4
. Noblia, P.; Vieites, M.; Torre, M. H.; Costa-Filho, A. J.; Cerecetto, H.; Gonzalez, M.;
Lavaggi, M. L.; Adachi, Y.; Sakurai, H.; Gambino, D. Novel vanadyl complexes with
1
4
quinoxaline N ,N -dioxide derivatives as potent in vitro insulin-mimetic compounds. J.
Inorg. Biochem. 2006, 100, 281–287.
6
. Amin, K. M.; Ismail, M. M. F.; Noaman, E.; Soliman, D. H.; Ammard, Y. A. New quin-
oxaline 1,4-di-N-oxides, part 1: Hypoxia-selective cytotoxins and anticancer agents
derived from quinoxaline 1,4-di-N-oxides. Bioorg. Med. Chem. 2006, 14, 6917–6923.
. Monge, A.; Palop, J. A.; Lopez de Cerain, A.; Senador, V.; Martinez, F. J.; Sainz, Y.;
Narro, S.; Garcia, E.; Carlos de Miguel.; Gonzalez, M.; Hamilton, E.; Barker, A. J.;
Clarke, E. D.; Greenhow, D. T. Hypoxia-selective agents derived from quinoxaline
7
1,4-Di-N-oxides. J. Med. Chem. 1995, 38, 1786–1792.
8. Chowdhury, G.; Kotandeniya, D.; Daniels, J. S.; Barnes, C. L.; Gates, K. S.
Enzyme-activated, hypoxia-selective DNA damage by 3-amino-2-quinoxalinecarbonitrile
1,4-di-N-oxide. Chem. Res. Toxicol. 2004, 17, 1399–1405.
9. Smith, P. A. S.; Boyer, J. H. Benzofurazan oxide II: Decomposition of o-nitrophenyl
hydrazide. Orga. Synth. Coll. Vol. 1963, 4, 74.
1
0. Monge, A.; Palop, J. A.; Del Castillo, J. C.; Calder o´ , J. M.; Roca, J.; Romero, G.; Del
Rio, J.; Lasheras, B. Novel antagonists of 5-HT3 receptors: Synthesis and biological
evaluation of piperazinylquinoxaline derivatives. J. Med. Chem. 1993, 36, 2745–2750.
1. Begland, R. W.; Hartter, D. R. Hydrogen cyanide chemistry, IV: Diiminosuccinonitrile
reactions with nucleophiles, acyl halides, and carbonyl compounds. J. Org. Chem. 1972,
1
37, 4136–4145.
1
1
1
1
1
1
1
1
2. Panayiotis, A. K.; Charles, W. R. Chemistry of 4-chloro-5-cyano-1,2,3-dithiazoliumchlor-
ide. J. Chem. Soc., Perkin Trans. 1 1999, 111–118.
3. Titov, V. V.; Kozhokina, L. F. Reactions of 2,2 ,3,3 -tetrachloro-6,6-diquinoxalyl with
nucleophilic reagents. Chem. Heterocycl. Comp. 1977, 13, 337–339.
4. Hermann, K.; Simchen, G. Synthese cyan-substituierter heterocyclen mit
tetraethyl-ammoniumcyanid. Liebigs Ann. Chem. 1981, 333–341.
5. Ferris, J. P.; Orgel, L. E. The reactions of bromomalorronitrile with bases. J. Org. Chem.
0
0
1965, 30, 2365–2367.
6. Pearson, R. G.; Dillon, R. L. Rates of ionization of pseudo acids IV: Relation between
rates and equilibria. J. Am. Chem. Soc. 1953, 75, 2439–2443.
7. Hart, H.; Kim, Y. C. A new synthesis of tetracyanocyclopropanes. J. Org. Chem. 1966, 31,
2784–2789.
8. Hart, H.; Freeman, F. The synthesis and NMR spectra of some tetracyanocyclopropanes.
J. Org. Chem. 1963, 28, 1220–1222.
9. Brown, D. J. The Chemistry of Heterocyclic Compounds: Quinoxalines Supplement II; John
Wiley & Sons: Hoboken, New Jersey, 2004; pp. 367.